These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1685691

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
    Bende M, Pipkorn U.
    Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
    Abelson MB, George MA, Schaefer K, Smith LM.
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):458-64. PubMed ID: 7916020
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
    Pipkorn U, Bende M, Hedner J, Hedner T.
    Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
    Abelson MB, George MA, Smith LM.
    Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
    [Abstract] [Full Text] [Related]

  • 31. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
    Søhoel P, Freng BA, Kramer J, Poppe S, Rebo R, Korsrud FR, Garud O, Woxen OJ, Olsen AK.
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):73-81. PubMed ID: 8101534
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
    Takamura E, Nomura K, Fujishima H, Fukagawa K, Satake Y, Fukada Y, Sawa M, Uchida E.
    Allergol Int; 2006 Jun; 55(2):157-65. PubMed ID: 17075252
    [Abstract] [Full Text] [Related]

  • 36. The role of levocabastine in the treatment of allergic rhinoconjunctivitis.
    Knight A.
    Br J Clin Pract; 1994 Jun; 48(3):139-43. PubMed ID: 7913336
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R, Pedersen B, Larsen B.
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.